These effects, together with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two support the strategy of targeting ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-connected Conditions.Importantly, these receptors were being